Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bright Minds Biosciences Inc C.DRUG

Alternate Symbol(s):  DRUG

Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant depression, post-traumatic stress disorder (PTSD), and pain. Its pipeline includes BMB-101, BMB-202, and BMB-xxx. BMB-101 is for the treatment of Dravet syndrome and other neurological and neuro-psychiatric disorders. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling while avoiding off-target effects.


CSE:DRUG - Post by User

Post by Possibleidiot01on Oct 16, 2024 4:39pm
59 Views
Post# 36268852

BrewMarkets mention - meme?

BrewMarkets mention - meme?

Good afternoon. The S&P 500 has gained 23% in 2024. Bright Minds Biosciences has gained 2,296% in the past five days.

The microcap Canadian pharma company hasn’t reported any revenue, yet shares exploded higher on Tuesday for…some reason? The Canadian Investment Regulatory Organization (basically the SEC, just more polite) reached out to the biotech for an explanation of why its stock suddenly soared out of the blue this week. The company’s answer was the verbal equivalent of a shrug emoji, with their spokesperson noting that nothing has materially changed about the company’s business.

The only thing that may explain the sudden stock surge: Bright Minds Biosciences’ ticker symbol is DRUG, which is exactly the sort of stock symbol meme traders love.



<< Previous
Bullboard Posts
Next >>